1.
J Eur Acad Dermatol Venereol
; 38(1): e106-e109, 2024 Jan.
Article
in English
| MEDLINE
| ID: mdl-37611279
Subject(s)
Prurigo , Humans , Prurigo/drug therapy , Heterocyclic Compounds, 3-Ring , Treatment Outcome
2.
J Eur Acad Dermatol Venereol
; 36(10): e776-e779, 2022 10.
Article
in English
| MEDLINE
| ID: mdl-35734956
3.
Br J Dermatol
; 185(4): 870-871, 2021 10.
Article
in English
| MEDLINE
| ID: mdl-34009646
4.
Clin Exp Dermatol
; 46(8): 1578-1579, 2021 Dec.
Article
in English
| MEDLINE
| ID: mdl-34048080
5.
Clin Exp Dermatol
; 46(6): 1123-1124, 2021 Aug.
Article
in English
| MEDLINE
| ID: mdl-33908085
Subject(s)
Antifungal Agents/therapeutic use , Candidiasis, Cutaneous/drug therapy , Candidiasis, Cutaneous/microbiology , Drug Resistance, Fungal , Intertrigo/drug therapy , Administration, Intravenous , Administration, Oral , Antifungal Agents/administration & dosage , Female , Humans , Micafungin/administration & dosage , Micafungin/therapeutic use , Middle Aged
6.
Actas dermo-sifiliogr. (Ed. impr.)
; 111(5): 436-439, jun. 2020. tab, ilus
Article
in Spanish
| IBECS
| ID: ibc-199367
ABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Dermatologic Agents/adverse effects , Methotrexate/adverse effects , Mucositis/chemically induced , Retrospective Studies
7.
Actas Dermosifiliogr (Engl Ed)
; 111(5): 436-439, 2020 Jun.
Article
in English, Spanish
| MEDLINE
| ID: mdl-32439124
Subject(s)
Methotrexate , Mucositis , Bone Marrow , Humans , Leucovorin , Methotrexate/adverse effects , Mucositis/chemically induced , Retrospective Studies
8.
Clin Exp Dermatol
; 45(6): 737-739, 2020 Aug.
Article
in English
| MEDLINE
| ID: mdl-32198945
Subject(s)
Pemphigus, Benign Familial/drug therapy , Pemphigus, Benign Familial/pathology , Phosphodiesterase 4 Inhibitors/therapeutic use , Thalidomide/analogs & derivatives , Adult , Chronic Disease , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pemphigus, Benign Familial/genetics , Phosphodiesterase 4 Inhibitors/administration & dosage , Phosphodiesterase 4 Inhibitors/adverse effects , Quality of Life , Severity of Illness Index , Thalidomide/administration & dosage , Thalidomide/adverse effects , Thalidomide/therapeutic use , Treatment Outcome
9.
Clin Exp Dermatol
; 45(3): 342-344, 2020 Apr.
Article
in English
| MEDLINE
| ID: mdl-31437867